The tumor ablation market is expected to be around US$ 1301 million by 2028 at a CAGR of 12.5%.
Ablation is minimally aggressive procedure in which a needle-like thin probe is announced through skin into a small lump. The technique uses raised temperature to eradicate alleviate blockages or tumors. CT, ultrasound or MRI is used to lead the probe into the lump. The probe products high-energy radio breakers or microwaves through its tip to heat and eliminate tumor. High demand for minimally invasive treatment procedures and growing awareness towards benefits of ablation procedures over conventional surgical procedures will drive the business growth. Better clinical significance pertaining to technical success making the procedure a believed oncologic treatment modality will produce massive development opportunities. Growing technical safety framework, rising funding to support ongoing research activities and public-private initiatives further offer great growth opportunities. Irreversible architectural deconstruction at a tissue level and fatal injury at cellular level by thermal effects may hamper the tumor ablation market growth. Growing inclination towards minimally invasive procedures owing to the benefits such as speedy recovery, patient comfort, and shorter turnaround time are the factors expected to foster the demand for advanced tumor ablation techniques during the estimate period. Integration of tumor ablation devices with efficient interventional imaging modalities like ultrasound, MRI, and CT is estimated to revolutionize ablation procedures performed in outpatient settings. This is projected to significantly eliminate the cost to the patient including hospital stays.
The global Tumor Ablation market is segregated on the basis of Mode of Treatment as Kidney Cancer, Bone Metastasis, Others, Liver Cancer, and Lung Cancer. Based on Technology the global Tumor Ablation market is segmented in Cryoablation, Other Technologies, Radiofrequency (RF) Ablation, and Microwave Ablation. Based on Deployment the global Tumor Ablation market is segmented in On-Premise, Cloud-Based, and Web-Based.
Based on Offering, the global Tumor Ablation market is segmented in Services and Software. The report also bifurcates the global Tumor Ablation market based on Product in Standalone Solutions and Integrated Solutions.
The global Tumor Ablation market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Tumor Ablation market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Neuwave Medical, Inc., Edap Tms S.A., Mermaid Medical A/S, Sonacare Medical, LLC, Misonix, Inc., Medtronic, PLC., Angiodynamics, Inc., Healthtronics, Inc., Galil Medical, Inc., Boston Scientific Corporation, and others are among the major players in the global Tumor Ablation market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Tumor Ablation Market has been segmented as below:
Tumor Ablation Market, By Mode of Treatment
Tumor Ablation Market, By Technology
Tumor Ablation Market, By Deployment
Tumor Ablation Market, By Offering
Tumor Ablation Market, By Product
Tumor Ablation Market, By Region
Tumor Ablation Market, By Company
The report covers:
Report Scope:
The global Tumor Ablation market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Tumor Ablation market share. Major industry players with significant revenue share include Neuwave Medical, Inc., Edap Tms S.A., Mermaid Medical A/S , Sonacare Medical, LLC , Misonix, Inc., Medtronic, PLC., Angiodynamics, Inc., Healthtronics, Inc., Galil Medical, Inc., Boston Scientific Corporation, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
Intracranial Pressure Monitor Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Tumor Ablation Market, By Mode of Treatment
5.1 Introduction
5.2 Kidney Cancer
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Bone Metastasis
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Others
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Liver Cancer
5.5.1 Market Overview
5.5.2 Market Size and Forecast
5.6 Lung Cancer
5.6.1 Market Overview
5.6.2 Market Size and Forecast
6. Tumor Ablation Market, By Technology
6.1 Introduction
6.2 Cryoablation
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Other Technologies
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Radiofrequency (RF) Ablation
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Microwave Ablation
6.5.1 Market Overview
6.5.2 Market Size and Forecast
7. Tumor Ablation Market, By Deployment
7.1 Introduction
7.2 On-Premise
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Cloud-Based
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Web-Based
7.4.1 Market Overview
7.4.2 Market Size and Forecast
8. Tumor Ablation Market, By Offering
8.1 Introduction
8.2 Services
8.2.1 Market Overview
8.2.2 Market Size and Forecast
8.3 Software
8.3.1 Market Overview
8.3.2 Market Size and Forecast
9. Tumor Ablation Market, By Product
9.1 Introduction
9.2 Standalone Solutions
9.2.1 Market Overview
9.2.2 Market Size and Forecast
9.3 Integrated Solutions
9.3.1 Market Overview
9.3.2 Market Size and Forecast
10. Tumor Ablation Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 North America Tumor Ablation, By Mode of Treatment
10.2.2 North America Tumor Ablation, By Technology
10.2.3 North America Tumor Ablation, By Deployment
10.2.4 North America Tumor Ablation, By Offering
10.2.5 North America Tumor Ablation, By Product
10.3 Europe
10.3.1 Europe Tumor Ablation, By Mode of Treatment
10.3.2 Europe Tumor Ablation, By Technology
10.3.3 Europe Tumor Ablation, By Deployment
10.3.4 Europe Tumor Ablation, By Offering
10.3.5 Europe Tumor Ablation, By Product
10.4 Asia-Pacific
10.4.1 Asia-Pacific Tumor Ablation, By Mode of Treatment
10.4.2 Asia-Pacific Tumor Ablation, By Technology
10.4.3 Asia-Pacific Tumor Ablation, By Deployment
10.4.4 Asia-Pacific Tumor Ablation, By Offering
10.4.5 Asia-Pacific Tumor Ablation, By Product
10.5 Rest of the World
10.5.1 Rest of the World Tumor Ablation, By Mode of Treatment
10.5.2 Rest of the World Tumor Ablation, By Technology
10.5.3 Rest of the World Tumor Ablation, By Deployment
10.5.4 Rest of the World Tumor Ablation, By Offering
10.5.5 Rest of the World Tumor Ablation, By Product
11. Competitive Insights
11.1 Key Insights
11.2 Company Market Share Analysis
11.3 Strategic Outlook
11.3.1 Mergers & Acquisitions
11.3.2 New Product Development
11.3.3 Portfolio/Production Capacity Expansions
11.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
11.3.5 Others
12. Company Profiles
12.1 Neuwave Medical, Inc.
12.1.1 Company Overview
12.1.2 Product/Service Landscape
12.1.3 Financial Overview
12.1.4 Recent Developments
12.2 Edap Tms S.A.
12.2.1 Company Overview
12.2.2 Product/Service Landscape
12.2.3 Financial Overview
12.2.4 Recent Developments
12.3 Mermaid Medical A/S
12.3.1 Company Overview
12.3.2 Product/Service Landscape
12.3.3 Financial Overview
12.3.4 Recent Developments
12.4 Sonacare Medical, LLC
12.4.1 Company Overview
12.4.2 Product/Service Landscape
12.4.3 Financial Overview
12.4.4 Recent Developments
12.5 Misonix, Inc.
12.5.1 Company Overview
12.5.2 Product/Service Landscape
12.5.3 Financial Overview
12.5.4 Recent Developments
12.6 Medtronic, PLC.
12.6.1 Company Overview
12.6.2 Product/Service Landscape
12.6.3 Financial Overview
12.6.4 Recent Developments
12.7 Angiodynamics, Inc.
12.7.1 Company Overview
12.7.2 Product/Service Landscape
12.7.3 Financial Overview
12.7.4 Recent Developments
12.8 Healthtronics, Inc.
12.8.1 Company Overview
12.8.2 Product/Service Landscape
12.8.3 Financial Overview
12.8.4 Recent Developments
12.9 Galil Medical, Inc.
12.9.1 Company Overview
12.9.2 Product/Service Landscape
12.9.3 Financial Overview
12.9.4 Recent Developments
12.10 Boston Scientific Corporation
12.10.1 Company Overview
12.10.2 Product/Service Landscape
12.10.3 Financial Overview
12.10.4 Recent Developments
The Tumor Ablation Market has been segmented as below:
Tumor Ablation Market, By Mode of Treatment
Tumor Ablation Market, By Technology
Tumor Ablation Market, By Deployment
Tumor Ablation Market, By Offering
Tumor Ablation Market, By Product
Tumor Ablation Market, By Region
Tumor Ablation Market, By Company
